4
Changes in Ownership
KALA BIO, Inc. Filed Acc 0001415889-24-000771
CHIEF BUSINESS OFFICER sold 1,385 shares at $6.73 ($9,321)
- CHIEF BUSINESS OFFICER acquired 4,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kharabi Darius CHIEF BUSINESS OFFICER | 2024-01-04 | Grant or award | +4,600 | 66,502 | D: show line 1 in the form | ||
| Kharabi Darius CHIEF BUSINESS OFFICER | 2024-01-04 | Sale | −1,385 | $6.73 | $9,321 | 65,117 | D: show line 2 in the form |
| Open-market sales · 1,385 sh · avg $6.73 · $9,321 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kharabi Darius CHIEF BUSINESS OFFICER | 2024-01-04 | Grant or award · Stock Option (right to buy) | +20,500 | 20,500 | D: show line 3 in the form |
Loading xslF345X05/form4-01052024_090101.xml…